MAPS phones the IRC-IRB and requests that the panel make a definite decision on whether it would require MAPS to hire a CRO and/or move to a multi-site design, neither of which MAPS is willing to do, before …
The IRB informed MAPS that it cannot proceed with its review until it obtains the advice of two “qualified, objective psychiatric consultants,” with fees for the consultants required to be …
More Documents. MAPS submitted a document detailing our standardized procedures for responding to “agitated subjects, or those with suicidal ideation associated with study procedures.” We also …
MAPS submitted a twelve page basic reply (which included in a bit of comic relief a required menu of the snack foods and drinks that we would offer to subjects on the MDMA therapy days and our plans for …
MAPS submitted a six page response focusing just on the issues of the Contract Research Organization and the multi-site study requirements, to be following up within a week or so with a more detailed discussion …
After the extensive discussions and good feelings of the January 28, 2003 in-person meeting, at which we seemingly discussed all the outstanding issues, the totally surprising reply sent by the IRC-IRB …
The January 28 meeting with the new IRB, at which Dr. Michael Mithoefer and Rick Doblin, Ph.D. appeared in person, involved a series of thoughtful questions about protocol design, risk assessment, confidentiality …
MAPS submitted a series of documents today to the IRC-IRB, in response to their initial comments about the protocol which MAPS received on January 6. These documents represent a very substantial amount …
Today, MAPS received the initial set of comments of the IRC-IRB. My initial impression is that we will eventually be able to get some protocol approved, but that we might need to limit enrollment to more …
MAPS submitted the MDMA/PTSD protocol for review to the Independent Review Consulting Institutional Review Board (IRC-IRB), with the protocol to be discussed by the review board on January 2, 2003. Officials …
On November 20, after the Western IRB decided not to review MAPS’ MDMA/PTSD protocol, Rick Doblin spoke to James Baldwin, Ph.D., Executive Director of the Western IRB. Dr. Baldwin informed Rick that …
Ron Warren, Senior Vice President of the Western IRB, wrote a letter to Dr. Michael Mithoefer, reporting the outcome of the November 19 meeting of the WIRB’s Executive Policy Committee. The WIRB …